Abstract
The growing significance of bioinformatics and systems biology in drug safety research requires a system of adverse-event classification that goes beyond a simple vocabulary. This opinion piece outlines the need for development of an ontology-based framework of describing adverse drug reactions (ADRs) and describes the potential applications for such a framework. © 2012 American Society for Clinical Pharmacology and Therapeutics.
Cite
CITATION STYLE
Zhichkin, P. E., Athey, B. D., Avigan, M. I., & Abernethy, D. R. (2012, June). Needs for an expanded ontology-based classification of adverse drug reactions and related mechanisms. Clinical Pharmacology and Therapeutics. https://doi.org/10.1038/clpt.2012.41
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.